Archive for the ‘sleeping’ tag

An Olympic celebrity in Vicks NuQuil campaign

without comments

normal_Nyquil-Esquire-January2010

Even Apolo Ohno gets sick. Vicks incorporated a celebrity in their current “better looking tomorrow” campaign.

Click here to see other executions from this campaign.

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Vicks NyQuil

without comments

Click here to see the original post on AdPharm

Visit AdPharm.net for more pharmaceutical ads

New NyQuil / DayQuil print campaign

without comments

Prevention - November 2009 Prevention - November 2009
DayQuil NyQuil
We’re all for sick days. Only without the sick part.
Vicks DayQuil. Powerful multi-symptom cold relief so you can power through the day.
For a better-looking tomorrow.
Vicks NyQuil. The nighttime, sniffing, sneezing, coughing, aching, fever, best sleep you ever got with a cold… medicine.

Brand name: Vicks DayQuil and NyQuil
Generic name/category: acetaminophen, dextromethorphan, pseudoephedrine hydrochloride
Company: Procter & Gamble
Country/Market: USA, North America
Indication(s)/use: Multi-symptom cold relief such as: nasal congestion, sore throat, headache, cough, minor aches and pains, muscular aches and fever
Target: Consumers (DTC)
Tagline: Vicks. Breathe life in
Medium: Print ad
Size/duration: single-page
Publication/Aired: Prevention – November 2009

To see all of this brand’s ads on AdPharm, click here

Doucenuit Anti-ronflement TV commercial

without comments

TV commercial

TV commercial

A woman sleeps in the living-room with the dog, in the kid’s short bed, in the bath because she snores.

[voice-over]
Vous avez oublié comme c’est bon de dormir avec votre partenaire?
Ne laissez pas les ronflements s’imiscer entre vous.
Doucenuit Anti-ronflements a une gamme de produits qui agissent toute la nuit pour vous aider.
Doucenuit, vivez enfin vos nuits en pleine harmonie.

[voice-over]
Have you forgotten how good it is to sleep with your partner?
Don’t let snoring come between you.
Doucenuit Anti-snoring has a family of products that can help you all night long.
Doucenuit, live your nights in full harmony.

Brand name: Doucenuit Anti-ronflement
Generic name/category: Family of snoring relief products
Company: Passion for life healthcare
Country/Market: France, Europe
Indication(s)/use: snoring
Target: Consumers (DTC)
Tagline: Doucenuit, vivez enfin vos nuits en pleine harmonie. – Doucenuit, live your nights in full harmony.
Medium: TV commercial
Size/duration: 20 seconds
Publication/Aired: 2009

ADHD disease awareness ad in Poland from Lilly

without comments

Click on thumbnail to view the full-size ad on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

Objawy ADHD Wystepuja
Occurring ADHD symptoms

Generic name/category: Disease awareness
Company: Lilly
Country/Market: Poland, Europe
Indication(s)/use: Attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: Answers that matter.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Gazeta Farmaceutyczn – June 2009

Vfend – Tick, tick, tick…

without comments

Login or subscribe to view this ad

For patients with life-threatening fungal infections
There's no time for a second chance

Voriconazole (VFEND, Pfizer) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who are immunocompromised, and include invasive candidiasis, invasive aspergillosis, and certain emerging fungal infections.

More on Wikipedia

Brand name: Vfend
Generic name/category: Voriconazole, Antifungals, Triazoles
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: invasive fungal infections, candidiasis, aspergillosis, and certain emerging fungal infections.
Target: Healthcare Professionals (HCP)
Tagline: When it matters most
Medium: Print ad
Size/duration: single-page
Publication/Aired: Blood – August 20, 2009

To see all of this brand's ads on AdPharm, click here
1 views
Sep 17, 2009

Visit AdPharm.net for more pharmaceutical ads

Rozerem

without comments


Demonstrated efficacy and safety in older patients, night after night

Rozerem did not impair balance or memory in older adults.

Ramelteon, marketed as Rozerem by Takeda Pharmaceuticals North America, is the first in a new class of sleep agents that selectively binds to the MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), versus binding to GABA A receptors, such as with drugs like zolpidem, eszopiclone, and zaleplon. Ramelteon is approved by the U.S. Food and Drug Administration (FDA) for long-term use.

Ramelteon does not show any appreciable binding to GABAA receptors, which are associated with anxiolytic, myorelaxant, and amnesic effects.

Ramelteon is used for insomnia, particularly delayed sleep onset. Ramelteon has not been shown to produce dependence and has shown no potential for abuse, and the withdrawal and rebound insomnia that is typical with other GABA modulators is not present in ramelteon. It is currently the only non-scheduled prescription drug for the treatment of insomnia available in the United States. Some clinicians also use ramelteon for the treatment of Delayed sleep phase disorder.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: Rozerem
Generic name/category: Ramelteon, Sedatives, Indanes
Company: Takeda Pharmaceuticals North America
Country/Market: USA, North America
Indication(s)/use: insomnia, difficulty with sleep onset
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration double-page spread
Publication/Aired: Pharmacy And Therapeutics – February 2008

To see all of this brand's ads on AdPharm, click here
0 views
Aug 25, 2009